Saccharides and their derivatives
|
Chitosan |
Immunoglobulin/mupirocin/Curcumin/sumatriptan/mucoadhesive loratadine/pelargonidin-3 -O-glucoside |
-
-
Increased bioactivity, bioavailability, and biostability during the oral digestion of the drug
-
-
Increased the capability of delaying the release of the drug in gastrointestinal simulated digestion after obtaining a high encapsulation efficiency in the liposome for the lowest particle size
-
-
Improved the physical properties of the liposomes
|
[63,64,65,66,67,68] |
Poly-galacturonic acid |
Nisin |
|
[69,70,71] |
Sodium alginate |
Calcitonin/Perilla Oil |
-
-
Increased the resistance of the membrane structure, the bioavailability, and the prolonged release of the drug
-
-
Provided good chemical stability and in vitro release behavior of the active compound
|
[72,73] |
Calcium alginate |
Oxaliplatin/Acid Folic/Ampicillin/Metformin |
|
[74,75] |
Pectin |
Resveratrol/Amoxicillin/Tagitinine C/Phlorizin |
-
-
Improved the long-term release of drugs and system stability
-
-
Presented small-sized liposomes with a slightly slower release
-
-
Improved immobilization, encapsulation efficiency, as well as physical storage stability of liposomes
|
[57,76,77] |
Starch |
Fasudil |
|
[78] |
Guar gum |
Hydrophobic bioactive compounds/Vitamin D3 |
|
[79,80] |
Xanthan gum |
Dioctadecyl dimethylammonium bromide |
|
[81] |
Cationic inulin |
Betaine/carvone |
|
[82] |
Galactomannan |
Ascorbic acid |
|
[83] |
Hyaluronic acid |
Antitumoral drug delivery/anti-melanoma agents (dacarbazine and eugenol) |
|
[84] |
Diethylaminomethyl-dextran |
Drug |
|
[85] |
Hydroxypropyl methylcellulose |
Sildenafil |
|
[86] |
Polymer/Copolymer
|
Polyethylene glycol PEG |
Vitexin |
|
[17,87,88] |
Poly (hydroxyethyl-l-asparagine) |
Antitumoral drugs |
|
[89,90] |
Poly(L-lysine) and poly (L-glutamic acid) |
Recommended for drug formulations |
|
[91] |
Eudragit EPO |
Curcumin |
-
-
Prolonged the release of the drug and improved the bioavailability upon oral administration
-
-
Improved the in vivo activity and enhanced the stability in the gastrointestinal tract of the active compound
|
[92] |
Proteins
|
Whey protein |
Astaxanthin, iron |
|
[93,94,95] |
Albumin |
Vancomycin/paclitaxel/ellagic acid |
-
-
Used as a drug-binding molecule to improve the long blood retention and biocompatibility
-
-
Increased the long release of the drug, showing superior deliverability for substances, high stability, effective loading content, and high capacity of controlled targeting
|
[96,97,98] |
Zein |
Indocyanine green |
|
[99] |
Silk fibroin (SF) |
Ibuprofen |
|
[100] |
Gelatine |
Arginyl-glycyl-aspartic acid/aspartic acid/Lactobacilli rhamnoses/Amphotericin B |
-
-
Increased the efficiency of drug delivery
-
-
Obtained small-sized liposomes, physically stable, with high drug encapsulation efficiency
|
[101,102] |
Collagen |
Dexamethasone |
|
[103] |
Combinations between groups of materials
|
Chitosan–gelatine |
ω-3 PUFA/BSA |
|
[104,105] |
Chitosan–sodium alginate |
Inactivated PR8 Influenza virus/cationic liposomes/resveratrol |
|
[106,107,108] |
Chitosan–pectin |
Neohesperidin/norfloxacin |
|
[109,110] |
Chitosan–arabic gum |
5I-1H-indole (5ID) |
|
[111] |
Chitosan–xanthan gum |
Pulmonary drugs |
|
[112] |
Chitosan–zein |
Pulicaria gnaphadoles (Vent) Boiss
|
|
[113] |
PEG–chitosan |
Doxorubicin/Stearoyl spermine |
|
[114] |
Pectin–whey protein |
Negatively and positively charged liposomes |
|
[115] |
Pectin–polygalacturonic acid |
Nisin |
|
[71] |
Whey protein, xanthan gum, tragacanth, arabic gum, and sodium alginate |
Gingerol |
-
-
Provided proper cell protection against oxidative stress
-
-
Increased the stability of the liposomes during storage
-
-
The liposomes maintained their structures in acidic and neutral media
|
[116] |
Other
|
Genipin (glycoside, cross-linker) |
Flaxseed oil/perilla oil/tannic acid |
-
-
Increased the bioavailability and prolonged the release of the drug
-
-
Improved physical and chemical properties, long-term stability, and in vitro release of the active compound
-
-
Obtained small-sized liposomes with high encapsulation efficiency and improved biocompatibility
|
[51,72,117,118] |
Silica |
Epirubicin-hydrochloride/Alfa-choriogonadotropin |
|
[119,120] |
Calciumcarbonate |
Drug |
|
[121] |
Ceramic |
Cholesterol |
|
[122] |